Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology

News   Jul 19, 2013

 
Solulink Completes Equity Financing for HybriLink™ Antibody-Labeling Technology
 
 
 

RELATED ARTICLES

Stem Cell Signaling Drives Mammary Gland Development

News

New research illuminates the biology of breast tissue development and may pave the way to new strategies for diagnosing or even treating cancer.

READ MORE

Faster Test for Cannabis Quality, Potency Developed

News

Traditional tests can take upwards of 20 minutes to perform, this new one can be done in under seven.

READ MORE

Inflammatory Bowel Disease Linked with Common Bacterial Gut Toxin

News

New research has uncovered a surprise link between a common bacterial toxin found in the gut and inflammatory bowel disease (IBD). It shows that breakdown products from the toxin seem to trigger gut inflammation that is characteristic of IBD.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE